bioRxiv / medRxiv
open access
CC BY-NC 4.0
Best Practice Manufacturing and Quality Standards for Bacteriophage Therapy Products: Australian Consensus Statements
ObjectiveAs antimicrobial resistance (AMR) continues to threaten global public health, bacteriophage therapy products (BTPs) offer a promising alternative to conventional antimicrobials. However, translation into routine clinical practice requires best practice standards for manufacturing and quali
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A review on phytochemical and bacteriophage based therapeutic strategies for the management of Brucellosis.#200758
- Bacteriophage therapy for Pseudomonas aeruginosa biofilms: mechanisms of resistance and novel treatment strategies#366765
- The Global Preclinical Antibacterial Pipeline#323869
- Genomic and functional characterization of a novel halophilic bacteriophage targeting carbapenem-resistant <i>Klebsiella pneumoniae</i>#236518
- Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings#648505
Record · ID 1124092
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive